Literature DB >> 29278832

An epidemic surge of influenza A(H3N2) virus at the end of the 2016-2017 season in Taiwan with an increased viral genetic heterogeneity.

Ji-Rong Yang1, Shu-Zhen Hsu1, Chuan-Yi Kuo1, Hsiang-Yi Huang1, Teng-Yung Huang1, Hsiao-Chi Wang1, Ming-Tsan Liu2.   

Abstract

BACKGROUND: The epidemic of the 2016-2017 influenza season in Taiwan started early with moderate activity and was predominated by the influenza A(H3N2) virus. However, the influenza activity increased dramatically during the late stage of the 2016-2017 season.
OBJECTIVES: The genetic and antigenic characteristics of the influenza A(H3N2) virus circulating in Taiwan during the 2016-2017 season were investigated. The relationship between virus clades and the patients' 2016-2017 vaccination histories was determined. STUDY
DESIGN: Respiratory samples from patients with influenza-like illness in the community, clustered outbreaks, and inpatients with severe complications were tested for influenza virus. Influenza gene sequencing, phylogenetic analysis and hemagglutination inhibition assay were performed.
RESULTS: A total of 1185, 690 and 353 cases of outpatients, inpatients and cluster events were tested positive for the A(H3N2) virus in this report. Multiple clades of the H3N2 virus co-circulated. New genetic variants were detected, including clade 3C.2a.1 with additional N121 K, K92R or T135 K mutations, 3C.2a.3a with T135 K and R150 K mutations and 3C.2a.4. The proportions of N121 K and T135 K mutations were continuously increasing. Most of the viruses (85.4%, 111/130) were antigenically related to the current vaccine strain. Infection by different clade H3N2 viruses did not correlate with immunization with the 2016-2017 vaccine.
CONCLUSIONS: The data in this study indicate that antigenic drift is not the primary determinant of the epidemic wave at the end of the 2016-2017 season. The fitness changes in new variants, waning immunity and climatic changes are considered as possible contributors to the resurgence of the influenza A(H3N2) virus.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Epidemic surge; Genetic variant; H3N2; Influenza virus

Mesh:

Substances:

Year:  2017        PMID: 29278832     DOI: 10.1016/j.jcv.2017.12.012

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  6 in total

1.  A cross-neutralizing antibody between HIV-1 and influenza virus.

Authors:  Chang-Chun D Lee; Yasunori Watanabe; Nicholas C Wu; Julianna Han; Sonu Kumar; Tossapol Pholcharee; Gemma E Seabright; Joel D Allen; Chih-Wei Lin; Ji-Rong Yang; Ming-Tsan Liu; Chung-Yi Wu; Andrew B Ward; Max Crispin; Ian A Wilson
Journal:  PLoS Pathog       Date:  2021-03-22       Impact factor: 6.823

2.  Increased genetic variation of A(H3N2) virus from influenza surveillance at the end of the 2016/2017 season for Shanghai port, China.

Authors:  Zilong Zhang; Shenwei Li; Xiaolin Zhu; Jian Hou; Hong Zhang; Baihui Zhao; Zhengan Tian
Journal:  Sci Rep       Date:  2022-10-12       Impact factor: 4.996

Review 3.  Centennial review of influenza in Taiwan.

Authors:  Yu-Nong Gong; Rei-Lin Kuo; Guang-Wu Chen; Shin-Ru Shih
Journal:  Biomed J       Date:  2018-09-10       Impact factor: 4.910

Review 4.  Dangerous Pathogens as a Potential Problem for Public Health.

Authors:  Edyta Janik; Michal Ceremuga; Marcin Niemcewicz; Michal Bijak
Journal:  Medicina (Kaunas)       Date:  2020-11-06       Impact factor: 2.430

5.  Applying Machine Learning Models with An Ensemble Approach for Accurate Real-Time Influenza Forecasting in Taiwan: Development and Validation Study.

Authors:  Hao-Yuan Cheng; Yu-Chun Wu; Min-Hau Lin; Yu-Lun Liu; Yue-Yang Tsai; Jo-Hua Wu; Ke-Han Pan; Chih-Jung Ke; Chiu-Mei Chen; Ding-Ping Liu; I-Feng Lin; Jen-Hsiang Chuang
Journal:  J Med Internet Res       Date:  2020-08-05       Impact factor: 5.428

6.  Characterizing the Countrywide Epidemic Spread of Influenza A(H1N1)pdm09 Virus in Kenya between 2009 and 2018.

Authors:  D Collins Owuor; Zaydah R de Laurent; Gilbert K Kikwai; Lillian M Mayieka; Melvin Ochieng; Nicola F Müller; Nancy A Otieno; Gideon O Emukule; Elizabeth A Hunsperger; Rebecca Garten; John R Barnes; Sandra S Chaves; D James Nokes; Charles N Agoti
Journal:  Viruses       Date:  2021-09-29       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.